Delivering the highest quality Medical Devices, Biological Medicines and Specialty Medicines to New Zealand

Te Arai Rare Disorders Medicines recommended for PHARMAC funding

Te Arai Rare Disorders Medicines recommended for PHARMAC funding

New recommendation for PHARMAC to fund sapropterin for PKU patients

New Medicine Sapropterin Registered

New Zealand is a step closer to funding the cardiovascular polypill

Microdacyn leads new Wound Care Review

Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications

World Health Organisation considers Trinomia® as an Essential Medicine

Microdacyn Leads The Way In New International Guidelines

UroFem receives ACC Listing

Te Arai BioFarma partners with Dipharma for high needs Medicines

Green Cross Health pharmacies to stock Microdacyn

Te Arai BioFarma continues environmental restoration

Clinical trials of D-mannose aid Antimicrobial Stewardship in New Zealand

Canterbury DHB completes evaluation of Microdacyn